The Combination of Lactoferrin and Creatine Ameliorates Muscle Decay in a Sarcopenia Murine Model

Wenbin Wu,Xinlu Guo,Taiqi Qu,Yuejia Huang,Jin Tao,Jian He,Xiaoping Wang,Junjie Luo,Peng An,Yinhua Zhu,Yanan Sun,Yongting Luo
DOI: https://doi.org/10.3390/nu16121958
IF: 5.9
2024-06-20
Nutrients
Abstract:Background: Sarcopenia is an age-related condition characterized by progressive loss of muscle mass, strength, and function. The occurrence of sarcopenia has a huge impact on physical, psychological, and social health. Therefore, the prevention and treatment of sarcopenia is becoming an important public health issue. Method: 35 six-week-old male C57BL/6 mice were randomly divided into five groups, one of which served as a control group, while the rest of the groups were constructed as a model of sarcopenia by intraperitoneal injection of D-galactose. The intervention with lactoferrin, creatine, and their mixtures, respectively, was carried out through gavage for 8 weeks. Muscle function was assessed based on their endurance, hanging time, and grip strength. The muscle tissues were weighed to assess the changes in mass, and the muscle RNA was extracted for myogenic factor expression and transcriptome sequencing to speculate on the potential mechanism of action by GO and KEGG enrichment analysis. Result: The muscle mass (lean mass, GAS index), and muscle function (endurance, hanging time, and grip strength) decreased, and the size and structure of myofiber was smaller in the model group compared to the control group. The intervention with lactoferrin and creatine, either alone or combination, improved muscle mass and function, restored muscle tissue, and increased the expression of myogenic regulators. The combined group demonstrated the most significant improvement in these indexes. The RNA-seq results revealed enrichment in the longevity-regulated pathway, MAPK pathway, focal adhesion, and ECM–receptor interaction pathway in the intervention group. The intervention group may influence muscle function by affecting the proliferation, differentiation, senescence of skeletal muscle cell, and contraction of muscle fiber. The combined group also enriched the mTOR-S6K/4E-BPs signaling pathway, PI3K-Akt signaling pathway, and energy metabolism-related pathways, including Apelin signaling, insulin resistance pathway, and adipocytokine signaling pathway, which affect energy metabolism in muscle. Conclusions: Lactoferrin and creatine, either alone or in combination, were found to inhibit the progression of sarcopenia by influencing the number and cross-sectional area of muscle fibers and muscle protein synthesis. The combined intervention appears to exert a more significant effect on energy metabolism.
nutrition & dietetics
What problem does this paper attempt to address?
### What problem does this paper attempt to solve? This paper primarily explores the effects of lactoferrin (Lf) and creatine (Cr), either used alone or in combination, on a mouse model of sarcopenia. Specifically: 1. **Improvement of muscle mass and function**: - The study found that D-galactose can induce a mouse model of sarcopenia. - By administering lactoferrin, creatine, and their combination, significant improvements in muscle mass and function were observed. 2. **Exploration of molecular mechanisms**: - RNA sequencing technology was used to analyze the muscle tissues of mice in different intervention groups. - It was found that these interventions might improve muscle function by affecting muscle cell proliferation, differentiation, aging, and contraction, with the combined intervention showing stronger effects on energy metabolism-related pathways. In summary, this study aims to verify whether lactoferrin and creatine can improve sarcopenia through individual or combined use and to explore their potential mechanisms of action.